InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Bar-Shalev Amos. Officer active across 1 company, notably Protalix BioTherapeutics, Inc.. Aggregated, 2 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €271. Activity tracked since 18 November 2025. The latest transaction was disclosed on 18 November 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations